[HTML][HTML] Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

G Schernthaner, N Shehadeh, AS Ametov… - Cardiovascular …, 2020 - Springer
The disclosure of proven cardiorenal benefits with certain antidiabetic agents was supposed
to herald a new era in the management of type 2 diabetes (T2D), especially for the many …

Obesity in South and Southeast Asia—A new consensus on care and management

KW Tham, R Abdul Ghani, SC Cua… - Obesity …, 2023 - Wiley Online Library
Obesity is a chronic disease in which the abnormal or excessive accumulation of body fat
leads to impaired health and increased risk of mortality and chronic health complications …

Mobile application interventions and weight loss in type 2 diabetes: a meta‐analysis

X Cai, S Qiu, D Luo, L Wang, Y Lu, M Li - Obesity, 2020 - Wiley Online Library
Objective This meta‐analysis aimed to assess the effect of mobile application (app)
interventions on weight loss in patients with type 2 diabetes. Methods Electronic databases …

[HTML][HTML] Silver Sulfadiazine Eradicates Antibiotic-Tolerant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms in Patients with Infected Diabetic Foot …

EG Di Domenico, B De Angelis, I Cavallo… - Journal of Clinical …, 2020 - mdpi.com
Infections are among the most frequent and challenging events in diabetic foot ulcers
(DFUs). Pathogenic bacteria growing in biofilms within host tissue are highly tolerant to …

[HTML][HTML] Liraglutide effects on glycemic control and weight in patients with type 2 diabetes Mellitus: A real-world, observational study and brief narrative review

CC Yousef, A Thomas, M Al Matar, L Ghandoura… - diabetes research and …, 2021 - Elsevier
Background Glycemic control and weight gain are two essential considerations in the
pharmacological management of type 2 diabetes mellitus. Pharmacological agents are …

[HTML][HTML] The Impact of Digital Self-Monitoring of Weight on Improving Diabetes Clinical Outcomes: Quasi-Randomized Study

Y Fundoiano-Hershcovitz, MD Ritholz… - Journal of Medical …, 2024 - jmir.org
Background The management of type 2 diabetes (T2D) and obesity, particularly in the
context of self-monitoring, remains a critical challenge in health care. As nearly 80% to 90 …

The safety and efficacy of once-weekly glucagon-like peptide-1 receptor agonist semaglutide in patients with type 2 diabetes mellitus: a systemic review and meta …

X Li, S Qie, X Wang, Y Zheng, Y Liu, G Liu - Endocrine, 2018 - Springer
Objectives To investigate the safety and efficacy of once-weekly glucagon-like peptide-1
(GLP-1) receptor agonist semaglutide as monotherapy or add-on to other …

Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions

AB Di Stefano, D Massihnia, F Grisafi… - European journal of cell …, 2019 - Elsevier
Angiogenesis is a crucial process for the maintenance of normal tissue physiology and it is
involved in tissue remodeling and regeneration. This process is essential for adipose tissue …

[HTML][HTML] Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity

Z Zhu, SYS Wong, JJY Sung, TYT Lam - Current Diabetes Reports, 2023 - Springer
Abstract Purpose of Review Numerous observations have indicated an increased risk of
developing various types of cancers, as well as cancer-related mortality, among patients …

Multidisciplinary Panel Consensus for the Management of Patients with Type 2 Diabetes: A Delphi Study

AM Cebrián-Cuenca, O Moreno-Pérez… - Archives of Medical …, 2024 - Elsevier
Aim To reach a multidisciplinary consensus on managing patients with type 2 diabetes
among specialists in family medicine, cardiology, endocrinology, internal medicine, and …